骨病

gǔ bìng
  • bone disease;osteopathy;osteopathia;osteonosus
骨病骨病
骨病[gǔ bìng]
  1. 目的:探讨CT引导下骨介入性诊断骨病、骨肿瘤的临床价值。

    Purpose : To study clinical diagnosis valence of bone biopsy of osteopathy and bone tumor under CT-guidance .

  2. 方法追踪观察1例肺性肥大性骨关节病病人16年,对双侧胫腓骨病变行19次X线检查,并行CT、MRI检查。

    Methods A case of hypertrophic osteoarthropathy was followed up for 16 years . The bilateral tibiofibula osteopathy was examined by X-ray ( 19 times ), CT and MRI respectively .

  3. 腰椎骨密度定量CT检测在肾性骨病早期诊断中的应用

    Measurement of Lumbar bone Mineral Density with Quantitative Computed Tomography in Renal Bone Disease

  4. 螺旋CT三维重建诊断骨病的方法及技术

    The Method and Technique in Diagnosis of Bony Disease by Using Three Dimensional Reconstruction of Spiral CT

  5. 目的研究核素显像与X线、CT、MRI联合诊断脊椎骨病的临床价值。提高诊断的准确性。

    Purpose To study value of joint diagnosis of spine disease with radionuclide imaging and radiological examination , increase the accuracy of diagnosis .

  6. IL-6及其受体在甲亢性代谢性骨病发病中的作用研究

    Research of Serum Interleukin-6 、 Souble IL-6 Receptor and Bone Metabolism in Patients with Grave 's Disease

  7. 结果:经骨显像并结合临床及普通X线或CT、MRI确诊为累及骨病变者12例,占24%。

    Result : Twelve cases ( 24 % , 12 / 50 ) had bone lesions diagnosed by bone imaging combined with radiography , CT and MRI among these cases .

  8. 用全身计数器测定~(99m)Tc-MDP全身滞留量诊断儿童和成年人代谢性骨病

    The use of a whole-body counter in the diagnosis of metabolic bone disease

  9. 目的肾性骨病(renalbonedisease)是慢性肾功能衰竭时发生的骨代谢障碍疾病,在肾病的早期就应重视骨代谢的改变并及早防治。

    Objective Renal osteodystrophy is a disease of bone metabolism disturbances with chronic renal failure ( CRF ) . It is necessary to take attention on changes of bone metabolism and have an early management .

  10. 结论胫骨超声速率(SOS)能够提供代谢性骨病的信息及骨强度的改变,对诊断代谢性骨病、骨质疏松症以及治疗前后骨密度的改变有一定的临床意义。

    Conclusion The tibia values of SOS provides a meaningful diagnostic criteria of bone density and bone quality .

  11. 结论高转换型肾性骨病中,PTH的溶骨作用可能是通过OPG/RANKL/RANK系统介导的。

    Conclusion OPG / RANKL / RANK system is involved in high turnover renal bone disease by parathyroid hormone .

  12. MM骨病的主要原因是破骨细胞活性增强,而不伴有相应的成骨细胞活性的增加,导致骨吸收增加。

    Myeloma bone disease is the result of an increased activity of osteoclasts , which is not accompanied by a comparable increase of osteoblast function , thus leading to enhanced bone resorption .

  13. VR对117例骨折和32例非外伤性骨病,不但能显示其外部和内部病变细节,而且能显示周围软组织受累状况,8例裂隙骨折及6例非外伤性骨病显示效果不理想。

    In 117 cases bone fractures and 32 cases non-flesh wounds osteopathy , not only demonstrated the detail , also demonstrated the soft tissue changes .

  14. 目的:对多发性骨髓瘤骨病(multiplemyelomaMM)的血钙及影像学特点进行总结,提高对MM骨病的认识。

    Objective : To the serum calcium and imaging features of bony disease in multiple myeloma ( MM ) to sum up , to elevate the diagnostic level of bony disease in MM .

  15. BMD测定敏感性较高,可以在慢性肾衰竭早期反映患者骨含量变化,是目前早期诊断肾性骨病的较好方法。

    And can reflect the changes of bone quantity in early CRF patients . It is a useful method for diagnosis of the early renal bone disease .

  16. 本文讨论了PTH水平与钙磷代谢、肾性骨病、肾性贫血、皮肤搔痒的关系。

    The relationship between serum PTH and the metabolism of calcium and phosphorus , renal osteopathy , renal anemia and pruritus was discussed .

  17. 适当补充维生素D3、降低体内IL-1β、IL-6和TNF-α水平,对防治肝性骨病可能具有重要意义。

    Adequate supplementation of vitamin D_3 and reducing serum levels of IL-1 β, IL-6 and TNF - α may be very important for prevention and treatment of hepatic bone disease .

  18. OPG和OPGL在多种骨病和牙正畸的治疗中具有很大潜力,具有良好的临床应用前景。

    OPG and OPGL have great potentiality in many kinds of bone diseases and orthodontic treatment and have good clinical application future .

  19. 破骨细胞分化因子(OsteoclastDifferentiationFactor,ODF)是近年来新发现的重要的骨代谢调节因子,它已经成为代谢性骨病领域的研究热点。

    Osteoclast differentiation factor ( ODF ) is the newly discovered factor which play an important role in regulating the metabolism of bone . It have become the focus of bone metabolism . ODF has complicated effection .

  20. 这些结果表明,血清BGP测定可以作为这些内分泌疾病及代谢性骨病的诊断、疗效观察的指标之一。

    It was shown by the present data that the serum BGP as an index of bone formation , was very valuable in patients with endocrine and metabolic bone diseases .

  21. 羟基磷灰石(HA)多孔生物陶瓷以其良好的生物性能在骨组织替代和修复、骨病治疗和组织重建等方面得到了越来越广泛的应用,具有良好的发展前景。

    Hydroxyapatite ( HA ) porous bioceramic with good biological properties has been more widely used in tissue replacement , repair of bone and bone disease treatment and tissue reconstruction , and has good prospects for the development .

  22. 目的:探讨蜡泪样骨病(Melorheostosis)的X线表现特点。

    Objective : To study the X-ray characteristics of melorheostosis .

  23. 提示:肝硬化患者血清1,25(OH)2D3降低与肝性骨病的发生关系密切,检测其水平,有利于该病的早期发现。

    These findings indicate that serum 1,25 ( OH ) 2D3 in patients with LC is closely related with HBD , and is a useful index for earlier detection of HBD .

  24. 用Z值对继发性甲状旁腺机能亢进症骨病(甲旁亢骨病)作诊断试验,受试者运筹特性曲线显示,当Z≤-2.2时,灵敏度为7941%,特异度为7815%。

    By using Z score to diagnose hyperparathyroidism bone disease , receiver operating characteristic ( ROC ) curve was worked out . If Z score ≤ - 2.2 , the sensitivity was 79.41 % and specificity was 78.15 % .

  25. 说明血清BGP测定与BMD一样可以作为骨质疏松、糖尿病等代谢性骨病诊断与研究的一种敏感指标。

    This indicates that determination of serum BGP , like BMD , can be used as a sensitive index for the diagnosis and study of such metabolic bone diseases as osteoporosis and diabetes .

  26. 结论肝硬化患者血清IL1β、TNFα水平升高可引起骨吸收加强,是肝性骨病(HBD)发生重要因素。

    Conclusion Elevation of serum IL-1 β and TNF - α in patients with cirrhosis can accelerate bone resorption and cause hepatic bone disease ( HBD ) .

  27. 结论BAP的测定对辅助诊断因钙营养不良引起的骨钙化障碍或其他原因引起的代谢性骨病,对儿童和孕产妇科学补钙有较大的指导作用。

    Conclusion Detection of BAP was useful for assisting the bone calcification dysfunction or calcium malnutrition , or for supplying calcium scientifically for children and pregnancy lying-in woman .

  28. 绝经后骨质疏松(PMO)是中老年妇女常见的代谢性骨病,随着人均寿命的延长,已日益成为突出的健康和社会问题。

    Postmenopausal osteoporosis is one of the most common metabolic diseases in old women . It has been a troublesome problem for public health and social life .

  29. 肾性骨病(RBD)又称肾性骨营养不良(renalbonedisease),是慢性肾功能衰竭引起的一组常见并发症,严重影响了患者的生存质量。

    Objective : this study is performed to examine the effect of the Bu-shen-huo-xue ( BSHX ) method on the abnormal bone metabolism of the renal bone disease in patients with chronic renal failure and quality of life of patients with renal bone disease .

  30. 目的检测小儿/成人血中骨源性碱性磷酸酶(BAP)活性,籍以筛查或辅助诊断因钙营养不良引起的骨钙化障碍或其他原因引起的代谢性骨病。

    Object To detect the activity of bone alkali phosphatase ( BAP ) in child / adult blood , to screen metabolic bone disease and bone calcification dysfunction for other reasons .